Education

The hub for all your learning resources.

Here you will find all our clinical education resources from articles to recorded webinars, all supporting equitable access to funded medicines.

2 minutes to Delve

Compliance, adherence, concordance – confused?

Whatever terminology is used, studies show that differences in health literacy, medicines access, attitudes to health and prescriber perceptions, may contribute to sub-optimal use of medicines and poor health outcomes.1

Read the HAH Bulletin to find out about strategies to improve medicine access/supply.

Contributor
He Ako Hiringa
24 May 2021
2 minutes to Read + 43 minutes to Explore

Focusing on the experiences of older Māori in primary care, this course comprises four short videos, an independent reflection, downloadable posters and additional resources.

The course is endorsed by RNZCGP and CNA(NZ) and meets PCNZ recertification requirements. Reflection templates are included for you to complete.

Contributor
Jo Hikaka
18 May 2021

This Quality Improvement Activity enables you to review the glycaemic management of your type 2 diabetes patients and identify those who may benefit from initiation or intensification of blood glucose lowering medicines.

Good glycaemic control has a clear benefit on microvascular outcomes and if started early enough, on long-term macrovascular outcomes of coronary artery disease, stroke and peripheral vascular disease.

Contributor
He Ako Hiringa
3 May 2021
20 minutes to Read

Māori attitudes to healthcare today are deeply rooted in New Zealand history. In this article, Deborah Bassett-Clarke discusses some reasons why the current model of pharmacy practice does not always meet the needs of Māori and may actually cause health inequities. Understanding these factors is an important first step to improving outcomes for Māori.

Contributor
Deborah Bassett-Clarke
30 April 2021
2 minutes to Delve

Medicine affordability is one of the five drivers of medicine access equity.

Up to 40 per cent of people continue to pay prescription copayments even though they are entitled to an exemption.No person or family should pay more than $100 per annum for subsidised medicines.

Read the HAH bulletin to find out more. 

Contributor
He Ako Hiringa
30 April 2021
4 minutes to Read

Your patient uses gliclazide and insulin but could still benefit from the additional cardiovascular and renal protections of empagliflozin. How would you manage the change in treatment? 

This case study is particularly relevant to prescribers. It originally appeared in the 3 March 2021 issue of New Zealand Doctor Rata Aotearoa and has been republished with permission.

Contributor
Penny Clark, Dr Linda Bryant
13 April 2021
11 minutes to Read

Current management of type 2 diabetes includes two new classes of medication, SGLT2 inhibitors and GLP-1 receptor agonists, where clinically indicated. This article was published in the April 2021 edition of Kai Tiaki. It has been edited specifically for our nursing readership from an article that appeared in New Zealand Doctor and Pharmacy Today late in 2020. 

This article is endorsed by the College of Nurses Aotearoa (NZ) Inc.

Contributor
Dr Rinki Murphy, Lisa Sparks
9 April 2021
3 minutes to Read

Capture, a new online tool, will help He Ako Hiringa members keep track of what they’re learning online.

Clicking the Capture button at the bottom of each educational piece will create a record of the time taken to read, watch or listen to that content. Members will also be able to record their thoughts and reflections on the content, creating a Capture Record that can then be downloaded and used as a record of learning.

Contributor
He Ako Hiringa
1 April 2021
65 minutes to Watch

In this webinar, Dr Ryan Paul discusses the changes to type 2 diabetes care in 2021, including when and how to use SGLT2 inhibitors and GLP-1 agonists. You can watch the webinar here or in ELearning. 

Downloadable empagliflozin patient information and a recent slide presentation can be found within this article.

Contributor
Dr Ryan Paul
4 March 2021